CN114716514A - 用于结肠清洁和胃肠病症治疗的组合物 - Google Patents

用于结肠清洁和胃肠病症治疗的组合物 Download PDF

Info

Publication number
CN114716514A
CN114716514A CN202210288669.XA CN202210288669A CN114716514A CN 114716514 A CN114716514 A CN 114716514A CN 202210288669 A CN202210288669 A CN 202210288669A CN 114716514 A CN114716514 A CN 114716514A
Authority
CN
China
Prior art keywords
cys
xaa
tyr
seq
glu leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202210288669.XA
Other languages
English (en)
Chinese (zh)
Inventor
M.G.卡里
R.索林加
C.莱泰泽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ironwood Pharmaceuticals Inc
Original Assignee
Ironwood Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ironwood Pharmaceuticals Inc filed Critical Ironwood Pharmaceuticals Inc
Publication of CN114716514A publication Critical patent/CN114716514A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN202210288669.XA 2015-05-01 2016-04-29 用于结肠清洁和胃肠病症治疗的组合物 Pending CN114716514A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562156077P 2015-05-01 2015-05-01
US62/156077 2015-05-01
CN201680032088.2A CN108040482B (zh) 2015-05-01 2016-04-29 用于结肠清洁和胃肠病症治疗的组合物
PCT/US2016/030061 WO2016178979A1 (en) 2015-05-01 2016-04-29 Compositions for colon cleansing and the treatment of gastrointestinal disorders

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201680032088.2A Division CN108040482B (zh) 2015-05-01 2016-04-29 用于结肠清洁和胃肠病症治疗的组合物

Publications (1)

Publication Number Publication Date
CN114716514A true CN114716514A (zh) 2022-07-08

Family

ID=55953439

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202210288669.XA Pending CN114716514A (zh) 2015-05-01 2016-04-29 用于结肠清洁和胃肠病症治疗的组合物
CN201680032088.2A Active CN108040482B (zh) 2015-05-01 2016-04-29 用于结肠清洁和胃肠病症治疗的组合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201680032088.2A Active CN108040482B (zh) 2015-05-01 2016-04-29 用于结肠清洁和胃肠病症治疗的组合物

Country Status (23)

Country Link
US (2) US10618938B2 (cg-RX-API-DMAC7.html)
EP (2) EP4218789A3 (cg-RX-API-DMAC7.html)
JP (5) JP6930919B2 (cg-RX-API-DMAC7.html)
KR (2) KR20250042844A (cg-RX-API-DMAC7.html)
CN (2) CN114716514A (cg-RX-API-DMAC7.html)
CA (2) CA3172777A1 (cg-RX-API-DMAC7.html)
CY (1) CY1126031T1 (cg-RX-API-DMAC7.html)
DK (1) DK3288578T5 (cg-RX-API-DMAC7.html)
EA (1) EA201792401A1 (cg-RX-API-DMAC7.html)
ES (1) ES2947591T3 (cg-RX-API-DMAC7.html)
FI (1) FI3288578T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20230381T1 (cg-RX-API-DMAC7.html)
HU (1) HUE061954T2 (cg-RX-API-DMAC7.html)
LT (1) LT3288578T (cg-RX-API-DMAC7.html)
MA (1) MA41985B1 (cg-RX-API-DMAC7.html)
MD (1) MD3288578T2 (cg-RX-API-DMAC7.html)
MX (2) MX2017013928A (cg-RX-API-DMAC7.html)
PL (1) PL3288578T3 (cg-RX-API-DMAC7.html)
PT (1) PT3288578T (cg-RX-API-DMAC7.html)
RS (1) RS64160B1 (cg-RX-API-DMAC7.html)
SI (1) SI3288578T1 (cg-RX-API-DMAC7.html)
SM (1) SMT202300114T1 (cg-RX-API-DMAC7.html)
WO (1) WO2016178979A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10618938B2 (en) * 2015-05-01 2020-04-14 Ironwood Pharmaceuticals, Inc. Compositions for colon cleansing and the treatment of gastrointestinal disorders
SI3464336T1 (sl) 2016-06-01 2022-06-30 Athira Pharma, Inc. Spojine
CA3238634A1 (en) * 2021-11-24 2023-06-01 Christopher Leitheiser Synthetic process for production of modified gcc receptor agonists
WO2023097210A1 (en) * 2021-11-24 2023-06-01 Ironwood Pharmaceuticals, Inc. Synthetic process for production of modified gcc receptor agonists
EP4440595A1 (en) * 2021-11-29 2024-10-09 Ironwood Pharmaceuticals, Inc. Pharmaceutical compositions for the treatment of visceral pain
WO2026050206A1 (en) * 2024-08-27 2026-03-05 Ironwood Pharmaceuticals, Inc. Combinations of glp-1 and guanylate cyclase c (gc-c) receptor agonists

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060094658A1 (en) * 2003-06-13 2006-05-04 Currie Mark G Method and compositions for the treatment of gastrointestinal disorders
CN1795007A (zh) * 2003-01-28 2006-06-28 米克罗比亚股份有限公司 治疗胃肠病的方法和组合物
WO2007022531A2 (en) * 2005-08-19 2007-02-22 Microbia, Inc. Methods and compositions for the treatment of gastrointestinal disorders
AU2009290137A1 (en) * 2008-09-03 2010-03-11 Xenome Ltd Libraries of peptide conjugates and methods for making them
WO2014131024A2 (en) * 2013-02-25 2014-08-28 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689139A5 (de) 1995-04-03 1998-10-30 Cerbios Pharma Sa Verfahren zur Herstellung einer liposomalen, in Wasser dispergierbaren, oral zu verabreichenden, festen, trockenen therapeutischen Formulierung.
US5912014A (en) 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
CA2790213A1 (en) * 2010-02-17 2011-08-25 Ironwood Pharmaceuticals, Inc. Treatments for gastrointestinal disorders
MX357121B (es) * 2011-03-01 2018-06-27 Synergy Pharmaceuticals Inc Star Proceso de preparacion de agonistas c de guanilato ciclasa.
PL3004138T3 (pl) * 2013-06-05 2024-07-29 Bausch Health Ireland Limited Ultra-oczyszczeni agoniści peptydowi cyklazy guanylanowej C, sposób ich uzyskiwania i ich zastosowanie
WO2016015055A1 (en) 2014-07-25 2016-01-28 Ironwood Pharmaceuticals, Inc. Colon cleansing compositions
US10618938B2 (en) 2015-05-01 2020-04-14 Ironwood Pharmaceuticals, Inc. Compositions for colon cleansing and the treatment of gastrointestinal disorders

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1795007A (zh) * 2003-01-28 2006-06-28 米克罗比亚股份有限公司 治疗胃肠病的方法和组合物
US20060094658A1 (en) * 2003-06-13 2006-05-04 Currie Mark G Method and compositions for the treatment of gastrointestinal disorders
WO2007022531A2 (en) * 2005-08-19 2007-02-22 Microbia, Inc. Methods and compositions for the treatment of gastrointestinal disorders
AU2009290137A1 (en) * 2008-09-03 2010-03-11 Xenome Ltd Libraries of peptide conjugates and methods for making them
WO2014131024A2 (en) * 2013-02-25 2014-08-28 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses

Also Published As

Publication number Publication date
MD3288578T2 (ro) 2023-08-31
RS64160B1 (sr) 2023-05-31
SMT202300114T1 (it) 2023-05-12
US10618938B2 (en) 2020-04-14
CY1126031T1 (el) 2023-11-15
JP7862355B2 (ja) 2026-05-19
FI3288578T3 (fi) 2023-05-03
EP3288578A1 (en) 2018-03-07
EP3288578B8 (en) 2023-03-29
US20180148476A1 (en) 2018-05-31
EP3288578B1 (en) 2023-03-15
JP2025169325A (ja) 2025-11-12
EP4218789A2 (en) 2023-08-02
MA41985B1 (fr) 2023-04-28
CA2984437A1 (en) 2016-11-10
EP4218789A3 (en) 2023-09-27
CN108040482B (zh) 2022-03-29
PT3288578T (pt) 2023-03-28
WO2016178979A1 (en) 2016-11-10
LT3288578T (lt) 2023-04-25
CA3172777A1 (en) 2016-11-10
KR20250042844A (ko) 2025-03-27
ES2947591T3 (es) 2023-08-11
CA2984437C (en) 2025-11-18
JP2018519254A (ja) 2018-07-19
MX2022013283A (es) 2022-12-13
JP2024015335A (ja) 2024-02-01
JP2020203954A (ja) 2020-12-24
DK3288578T5 (da) 2024-10-07
SI3288578T1 (sl) 2023-07-31
KR20180005675A (ko) 2018-01-16
KR102783759B1 (ko) 2025-03-21
CN108040482A (zh) 2018-05-15
JP2022121734A (ja) 2022-08-19
DK3288578T3 (da) 2023-05-01
HUE061954T2 (hu) 2023-09-28
JP6930919B2 (ja) 2021-09-01
HRP20230381T1 (hr) 2023-07-07
PL3288578T3 (pl) 2023-08-14
EA201792401A1 (ru) 2018-05-31
MA41985A (fr) 2018-03-07
MX2017013928A (es) 2018-01-15
US20240199697A1 (en) 2024-06-20
BR112017023539A2 (pt) 2018-08-14

Similar Documents

Publication Publication Date Title
TWI482626B (zh) 胃腸道病症的治療
JP7862355B2 (ja) 結腸洗浄及び胃腸障害の治療のための組成物
CN102869677B (zh) 胃肠病症的治疗
JP2025116257A (ja) 消化器疾患の治療
US8735360B2 (en) Treatments for gastrointestinal disorders
WO2012155114A1 (en) Peptides derived from uroguanylin and their use in gastrointestinal disorders
HK40080323A (en) Compositions for colon cleansing and the treatment of gastrointestinal disorders
HK40097176A (en) Compositions for colon cleansing and the treatment of gastrointestnal disorders
BR112017023539B1 (pt) Peptídeos ou sais farmaceuticamente aceitáveis do mesmo, seus métodos de produção, seus usos e composições farmaceuticas
EA048992B1 (ru) Композиции для очищения толстого кишечника и лечения желудочно-кишечных расстройств
HK1179637B (en) Treatment for gastrointestinal disorders
EA053280B1 (ru) Композиции для очищения толстого кишечника и лечения желудочно-кишечных расстройств
HK1179637A (en) Treatment for gastrointestinal disorders

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40080323

Country of ref document: HK

RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20220708